| Quitkin, Frederic M; McGrath, Patrick J; Stewart, Jonathan W et al. (2005) Remission rates with 3 consecutive antidepressant trials: effectiveness for depressed outpatients. J Clin Psychiatry 66:670-6 |
| Quitkin, F M; McGrath, P J; Stewart, J W et al. (1998) Placebo run-in period in studies of depressive disorders. Clinical, heuristic and research implications. Br J Psychiatry 173:242-8 |
| Quitkin, F M; McGrath, P J; Stewart, J W et al. (1996) Can the effects of antidepressants be observed in the first two weeks of treatment? Neuropsychopharmacology 15:390-4 |
| Quitkin, F M; McGrath, P J; Stewart, J W et al. (1996) Chronological milestones to guide drug change. When should clinicians switch antidepressants? Arch Gen Psychiatry 53:785-92 |
| Quitkin, F M; Stewart, J W; McGrath, P J et al. (1993) Further evidence that a placebo response to antidepressants can be identified. Am J Psychiatry 150:566-70 |
| Stewart, J W; McGrath, P J; Rabkin, J G et al. (1993) Atypical depression. A valid clinical entity? Psychiatr Clin North Am 16:479-95 |
| McGrath, P J; Stewart, J W; Tricamo, E et al. (1993) Paradoxical mood shifts to euthymia or hypomania upon withdrawal of antidepressant agents. J Clin Psychopharmacol 13:224-5 |
| McGrath, P J; Stewart, J W; Nunes, E V et al. (1993) A double-blind crossover trial of imipramine and phenelzine for outpatients with treatment-refractory depression. Am J Psychiatry 150:118-23 |
| Quitkin, F M; Stewart, J W; McGrath, P J et al. (1993) Loss of drug effects during continuation therapy. Am J Psychiatry 150:562-5 |
| Stewart, J W; McGrath, P J; Quitkin, F M (1992) Can mildly depressed outpatients with atypical depression benefit from antidepressants? Am J Psychiatry 149:615-9 |
Showing the most recent 10 out of 21 publications
